R Squared LTD Xeris Biopharma Holdings, Inc. Transaction History
R Squared LTD
- $93.6 Billion
- Q1 2025
A detailed history of R Squared LTD transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, R Squared LTD holds 15,730 shares of XERS stock, worth $70,942. This represents 0.09% of its overall portfolio holdings.
Number of Shares
15,730
Previous 12,320
27.68%
Holding current value
$70,942
Previous $41.8 Million
106.77%
% of portfolio
0.09%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding XERS
# of Institutions
187Shares Held
71.4MCall Options Held
117KPut Options Held
35.3K-
Black Rock Inc. New York, NY10.3MShares$46.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$36.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.41MShares$15.4 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$15.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$13 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $613M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...